Chuang P, Su W, Hsieh C, Huang E
Cells. 2025; 14(5).
PMID: 40072068
PMC: 11898548.
DOI: 10.3390/cells14050339.
Thayer-Freeman C, Washington B, Fabian D, Cheek D, Clair W, Bernard M
Adv Radiat Oncol. 2025; 10(3):101725.
PMID: 40062322
PMC: 11889347.
DOI: 10.1016/j.adro.2025.101725.
Ayele S, Tsige A
Health Sci Rep. 2025; 8(2):e70506.
PMID: 39995791
PMC: 11848730.
DOI: 10.1002/hsr2.70506.
Kouri A, Darby J
Curr Treat Options Oncol. 2025; .
PMID: 39969757
DOI: 10.1007/s11864-025-01299-4.
Yang C, Zou J, Luo X, Ou Y, Lin X, Wang X
BMC Public Health. 2025; 25(1):590.
PMID: 39939993
PMC: 11823132.
DOI: 10.1186/s12889-025-21807-3.
SLC7A11 is a potential therapeutic target and prognostic biomarker correlated with immune cell infiltration in cervical cancer.
Guy M, Bian T, Sun L, Hao Y, Jiao X, Zhang W
Discov Oncol. 2025; 16(1):125.
PMID: 39915437
PMC: 11802985.
DOI: 10.1007/s12672-025-01888-7.
Symptoms associated with concurrent chemoradiotherapy in patients with cervical cancer: Application of latent profile analysis and network analysis.
Lu X, Zheng L, Jin X, Wang Y, Wu S, Lv Y
Asia Pac J Oncol Nurs. 2025; 12:100649.
PMID: 39896759
PMC: 11786907.
DOI: 10.1016/j.apjon.2024.100649.
Prognostic and diagnostic value of circRNA expression in cervical cancer: a meta analysis.
Xu Y, Li C, Cheng L, Wang S, Wu Y, Li S
Front Oncol. 2025; 14:1488040.
PMID: 39871946
PMC: 11769824.
DOI: 10.3389/fonc.2024.1488040.
Molecule interacting with CasL-2 enhances tumor progression and alters radiosensitivity in cervical cancer.
Teng Y, Zhao H, Xue G, Zhang G, Huang Y, Guo W
J Transl Med. 2025; 23(1):44.
PMID: 39799334
PMC: 11725214.
DOI: 10.1186/s12967-024-06065-y.
Cost Analysis Related to Diagnosis, Treatment and Management of Cervical Cancer in Antigua and Barbuda: A Prevalence-Based Cost-of-Illness Study.
Bovell A, Ngcamphalala C, Abbott D, Ncayiyana J, Ginindza T
Int J Environ Res Public Health. 2025; 21(12.
PMID: 39767524
PMC: 11675278.
DOI: 10.3390/ijerph21121685.
Pharmacoeconomic Analysis of Treating Gynecological Cancer with Different Regimens Using the Cheapest and Costliest Brand of Drugs Marketed in India.
Krishna A, Jayachandran M, Sacheendran D, Simon P, George T, Palatty P
J Obstet Gynaecol India. 2025; 74(6):489-497.
PMID: 39758579
PMC: 11693631.
DOI: 10.1007/s13224-023-01905-1.
Outcomes of Laparoscopic Radical Hysterectomy in Ia1-Ib1 Cervical Cancer Patients: A Multi-Center Study with 10 Years' Experiences in the Real World.
Zhang C, Tian W, Zhou X, Li L, Tan S, Sun L
Ann Surg Oncol. 2024; 32(3):2213-2222.
PMID: 39739265
PMC: 11811253.
DOI: 10.1245/s10434-024-16637-3.
Adjuvant Chemotherapy versus Concurrent Chemoradiotherapy for Surgically Treated T1b Uterine Cervical Cancer: A Propensity Score Matched Analysis of the JSOG Nationwide Data.
Tanaka Y, Higami S, Ishii T, Shiki Y, Ueda Y, Kimura T
Ann Surg Oncol. 2024; 32(3):2206-2212.
PMID: 39663326
DOI: 10.1245/s10434-024-16638-2.
CaCO-encircled hollow CuS nanovehicles to suppress cervical cancer through enhanced calcium overload-triggered mitochondria damage.
Wang P, Sun X, Tang L, Li N, Wang Q, Gan B
Asian J Pharm Sci. 2024; 19(6):100989.
PMID: 39640053
PMC: 11616050.
DOI: 10.1016/j.ajps.2024.100989.
Association of Inflammatory Factors with Cervical Cancer: A Bidirectional Mendelian Randomization.
Li Q, Kaidong L, Tian Z, Diao W, Sun Y, Bai Y
J Inflamm Res. 2024; 17:10119-10130.
PMID: 39639927
PMC: 11619112.
DOI: 10.2147/JIR.S493854.
Lymph node assessment in cervical cancer: current approaches.
Dheur A, Kakkos A, Danthine D, Delbecque K, Goffin F, Gonne E
Front Oncol. 2024; 14:1435532.
PMID: 39588308
PMC: 11586254.
DOI: 10.3389/fonc.2024.1435532.
Yinjia pills inhibits the malignant biological behavior of HeLa cells through PKM2-medicated inhibition of JAK/STAT3 pathway.
Shi Y, Min X, Li Y, Guo L, Cai Z, Li D
Cytotechnology. 2024; 77(1):5.
PMID: 39575323
PMC: 11579276.
DOI: 10.1007/s10616-024-00668-5.
The complexity and challenges of fertility preservation in women with cervix cancer-A prospective cohort study reporting on reproductive outcome and overall survival.
Marklund A, Jiang Y, Rojlar H, Sergouniotis F, Nilsson H, Lundberg F
Acta Obstet Gynecol Scand. 2024; 104(1):86-94.
PMID: 39568130
PMC: 11683558.
DOI: 10.1111/aogs.15007.
Risks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types.
Aimagambetova G, Bapayeva G, Ukybassova T, Kamzayeva N, Sakhipova G, Shanazarov N
J Clin Med. 2024; 13(21).
PMID: 39518458
PMC: 11547075.
DOI: 10.3390/jcm13216318.
High-grade cervical disease and cervical cancer in women aged 50 years and older compared with younger women: examining prevalence by HIV status in two large prospective cohorts in Botswana.
Luckett R, Zhang B, Gompers A, George J, Modest A, Bazzett-Matabele L
BMJ Open. 2024; 14(10):e089375.
PMID: 39477271
PMC: 11529474.
DOI: 10.1136/bmjopen-2024-089375.